⌘K

Home/Filings/4/0001171843-16-007714

4//SEC Filing

Anika Therapeutics, Inc. 4

Accession 0001171843-16-007714

$ANIKCIK 0000898437operating

View on SEC.gov Company Profile

Filed

Feb 7, 7:00 PM ET

Accepted

Feb 8, 4:05 PM ET

Size

7.1 KB

Accession

0001171843-16-007714

Insider Transaction Report

Form 4

Period: 2016-02-04

Anika Therapeutics, Inc.ANIK

Chief Tech. & Strategy Officer

Transactions

Award
Common Stock
2016-02-04+7,900→ 7,900 total
Award
Stock Option (Right to Buy)
2016-02-04+18,300→ 18,300 total
Exercise: $38.11Exp: 2026-02-04→ Common Stock (18,300 underlying)

Footnotes (2)

[F1]Restricted stock awards vest in four equal annual installments beginning February 4, 2017.
[F2]The stock options vest in four equal annual installments beginning February 4, 2017.

Documents

1 file

4
formfour.xmlPrimary

Issuer

Anika Therapeutics, Inc.

CIK 0000898437

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000898437

Filing Metadata

Form type: 4
Filed: Feb 7, 7:00 PM ET
Accepted: Feb 8, 4:05 PM ET
Size: 7.1 KB

View on SEC.gov